Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): A successful biopsychosocial approach to the treatment of alcoholism

Dialogues in Clinical Neuroscience

Volumn 9, Issue 4, 2007, Pages 399-412

  Krampe, Henning ^a   Stawicki, Sabina ^a   Hoehe, Margret R ^b   Ehrenreich, Hannelore ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Addiction; Alcohol; Alcoholism therapy; Chronic psychiatric disease; Integrated long term treatment; Therapeutic alliance; Therapy process and outcome

Indexed keywords

ALCOHOL; CALCIUM CARBIMIDE; CYANAMIDE; DISULFIRAM;

ALCOHOL ABSTINENCE; ALCOHOLISM; ANXIETY DISORDER; CASE CONTROL STUDY; CLINICAL PRACTICE; CONVALESCENCE; DEPRESSION; HUMAN; INTENSIVE CARE; LONG TERM CARE; OUTCOME ASSESSMENT; PERSONALITY DISORDER; PHYSICAL STRESS; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PSYCHOSOCIAL CARE; PSYCHOTHERAPIST; REVIEW; TREATMENT OUTCOME;

ADULT; ALCOHOLISM; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTPATIENTS; PERSONALITY DISORDERS; PSYCHOTHERAPY; QUESTIONNAIRES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38549094576     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Bray J, Zarkin G. Economic evaluation of alcoholism treatment. Alcohol Res Health. 2006;29:27-33.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.
3. Nalpas B, Combescure C, Pierre B, et al. Financial costs of alcoholism treatment programs: a longitudinal and comparative evaluation among four specialized centers. Alcohol Clin Exp Res. 2003;27:51-56.
4. O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet. 1996;347:237-240.
5. Uhl GR, Grow RW. The burden of complex genetics in brain disorders. Arch Gen Psychiatry. 2004;61:223-229.
6. Caetano R, Cunradi C. Alcohol dependence: a public health perspective. Addiction. 2002;97:633-645.
7. Jacobi F, Wittchen HU, Hoelting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34:597-611.
8. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Study. Arch Gen Psychiatry. 1994;51:8-19.
9. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
10. Rehm J, Room R, Vandenbrink W, Jacobi F. Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol. 2005;15:377-388.
11. Wittchen H-U, Essau CA, von Zerssen D, Krieg J-C, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich Follow-up Study. Eur Arch Psychiatry Clin Neurosci. 1992;241:247-258.
12. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313-321.
13. Ross HE. DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: Results from the Mental Health Supplement to the Ontario Health Survey. Drug Alcohol Depend. 1995;39:111-128.
14. Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry. 2001;16:274-282.
15. van den Bosch L, Verheul R. Patients with addiction and personality disorder: treatment outcomes and clinical implications. Curr Opin Psychiatry. 2007;20:67-71.
16. John U, Hanke M. Alcohol-attributable mortality in a high per capita consumption country - Germany. Alcohol Alcohol. 2002;37:581-585.
17. Rehm J, Taylor B, Patra J. Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002. Addiction. 2006;101:1086-1095.
18. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci. 2003;26:507-513.
19. Bigelow GE. An operant behavioral perspective on alcohol abuse and dependence. In: Heather N, Peters TJ, Stockwell T, eds. International Handbook of Alcohol Dependence and Problems. Chichester, UK: John Wiley & Sons Ltd; 2001:299-316.
20. Breese GR, Chu K, Dayas CV, et al. Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res. 2005;29:185-195.
21. Collins RL, Bradizza CM. Social and cognitive learning processes. In: Heather N, Peters TJ, Stockwell T, eds. International Handbook of Alcohol Dependence and Problems. Chichester, UK: John Wiley & Sons; 2001:317-337.
22. Dackis C, O'Brien C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci. 2005;8:1431-1436.
23. Doering WK, Herzenstiel M-N, Krampe H, et al. Persistent alterations of vasopressin and NT-pro-ANP plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res. 2003;27:849-861.
24. Drobes DJ, Saladin ME, Tiffany ST. Classical conditioning mechanisms in alcohol dependence. In: Heather N, Peters TJ, Stockwell T, eds. International Handbook of Alcohol Dependence and Problems. Chichester, UK: John Wiley & Sons Ltd; 2001:281-298.
25. Drummond DC, Tiffany ST, Glautier S, Remington B, eds. Addictive Behaviour: Cue Exposure Theory and Practice. Chichester, UK: John Wiley & Sons; 1995.
26. Ehrenreich H, Schuck J, Stender N, et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res. 1997;21:1285-1293.
27. Finn PR, Zeitouni NC, Pihl RO. Effects of alcohol on psychophysiological hyperreactivity to nonaversive and aversive stimuli in men at high risk for alcoholism. J Abnorm Psychol. 1990;99:79-85.
28. Flannery BA, Roberts AJ, Cooney N, Swift RM, Anton RF, Rohsenow DJ. The role of craving in alcohol use, dependence, and treatment. Alcohol Clin Exp Res. 2001;25:299-308.
29. Gifford E, Humphreys K. The psychological science of addiction. Addiction. 2007;102:352-361.
30. Greeley J, Oei T. Alcohol and tension reduction. In: Leonard KE, Blane HT, eds. Psychological Theories of Drinking and Alcoholism. 2nd ed. New York, NY: The Guilford Press; 1999:14-53.
31. Hasselblatt M, Martin F, Maul O, Ehrenreich H. Persistent macrocytosis following abstinence from chronic alcohol use. JAMA. 2001;286:2946.
32. Hasselblatt M, Krieg-Hartig C, Hüfner M, Halaris A, Ehrenreich H. Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men. Alcohol Alcohol. 2003;38:239-242.
33. Hasselblatt M, Krampe H, Jacobs S, et al. Arginine challenge unravels persistent disturbances of urea cycle and gluconeogenesis in abstinent alcoholics. Alcohol Alcohol. 2006;41 372-378.
34. Hüttner E, Matthies U, Nikolova T, Ehrenreich H. A follow-up study on chromosomal aberrations in lymphocytes of alcoholics during early, medium, and long-term abstinence. Alcohol Clin Exp Res. 1999;23:344-348.
35. Jahn H, Doering W, Krampe H, et al. Preserved vasopressin response to osmostimulation despite decreased basal vasopressin levels in long-term abstinent alcoholics. Alcohol Clin Exp Res. 2004;28:1925-1930.
36. Jones S, Bonci A. Synaptic plasticity and drug addiction. Curr Opin Pharmacol. 2005;5:20-25.
37. Kendler KS. Twin studies of psychiatric illness: An update. Arch Gen Psychiatry. 2001;58:1005-1014.
38. Koob GF. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction. 2006;101(suppl 1):23-30.
39. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
40. Koob G, Kreek M. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007;164:1149-1159.
41. Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron. 1998;21:467-476.
42. Lingford-Hughes A, Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry. 2003;182:97-100.
43. Liu X, Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: Exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci. 2002;22:7856-7861.
44. Lubman DI, Yucel M, Pantelis C. Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction. 2004;99:1491-1502.
45. Marlatt GA, Gordon JR. Relapse Prevention. Maintenance Strategies in the Treatment of Addictive Behaviors. New York, NY: Guilford Press, 1985.
46. Monti PM, Rohsenow DJ, Hutchison KE. Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving. Addiction. 2000;95:S229-S36.
47. Moos RH. Theory-based processes that promote the remission of substance use disorders. Clin Psychol Rev. 2007;27:537-551.
48. Petrakis IL, Limoncelli D, Gueorguieva R, et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry. 2004;161:1776-1182.
49. Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature. 1999;398:567-570.
50. Schmidt LG, Dufeu P, Kuhn S, Smolka M, Rommelspacher H. Transition to alcohol dependence: Clinical and neurobiological considerations. Compr Psychiatry. 2000;41:90-94.
51. Schmitt M, Gleiter CH, Nichol JL, et al. Haematological abnormalities in early abstinent alcoholics are closely associated with alterations in thrombopoietin and erythropoietin serum profiles. Thromb Haemost. 1999;82:1422-1427.
52. Schuckit MA. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry. 1994;151:184-189.
53. Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry. 1996;53:202-210.
54. Schumann G. Okey Lecture 2006: identifying the neurobiological mechanisms of addictive behaviour. Addiction. 2007;102:1689-1695.
55. Spanagel R. Alcohol addiction research: from animal models to clinics. Best Pract Res Clin Gastroenterol. 2003;17:507-518.
56. Spanagel R, Heilig M. Addiction and its brain science. Addiction. 2005;100:1813-1822.
57. Volkow ND, Li T-K. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neuroscience. 2004;5:963-970.
58. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol. 2005;5:9-19.
59. Weiss F, Porrino U. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci. 2002;22:3332-3337.
60. vanderVorst H, Engels RCME, Dekovic M, Meeus W, Vermulst AA. Alcohol specific rules, personality and adolescents' alcohol use: a longitudinal person-environment study. Addiction. 2007;102:1064-1075.
61. West R. Theories of addiction. Addiction. 2001;96:3-13.
62. Zimmermann U, Spring K, Wittchen HU, et al. Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers. J Psychiatr Res. 2004;38:385-593.
63. Finney JW, Moos RH. The long-term course of treated alcoholism: I. Mortality, relapse and remission rates and comparisons with community controls. J Stud Alcohol. 1991;52:44-54.
64. Hunter EE, Powell BJ, Penick EC, et al. Comorbid psychiatric diagnosis and long-term drinking outcome. Compr Psychiatry. 2000;41:334-338.
65. Lewis CE, Smith E, Kercher C, Spitznagel E. Assessing gender interactions in the prediction of mortality in alcoholic men and women: a 20-year follow-up study. Alcohol Clin Exp Res. 1995;19:1162-1172.
66. Liskow BI, Powell BJ, Penick EC, et al. Mortality in male alcoholics after ten to fourteen years. J Stud Alcohol. 2000;61:853-861.
67. Moos RH, Moos BS. Risk factors for nonremission among initially untreated individuals with alcohol use disorders. J Stud Alcohol. 2003;64:555-563.
68. Ojesjo L, Hagnell O, Otterbeck L. The course of alcoholism among men in the Lundby longitudinal study, Sweden. J Stud Alcohol. 2000;61:320-322.
69. Penick EC, Nickel EJ, Powell BJ, et al. The comparative validity of eleven alcoholism typologies. J Stud Alcohol. 1999;60:188-202.
70. Powell BJ, Landon JF, Cantrell PJ, et al. Prediction of drinking outcomes for male alcoholics after 10 to 14 years. Alcohol Clin Exp Res. 1998;22:559-566.
71. de Soto CB, O'Donnell WE, de Soto JL. Long-term recovery in alcoholics. Alcohol Clin Exp Res. 1989;13:693-697.
72. Timko C, DeBenedetti A, Moos B, Moos R. Predictors of 16-year mortality among individuals initiating help-seeking for an alcoholic use disorder. Alcohol Clin Exp Res. 2006;30:1711-1720.
73. Vaillant GE. The Natural History of Alcoholism - Revisited. Cambridge, Mass: Harvard University Press, 1995.
74. Vaillant GE. A long-term follow-up of male alcohol abuse. Arch Gen Psychiatry. 1996;53:243-249.
75. Vaillant GE. A 60-year follow-up of alcoholic men. Addiction. 2003;98:1043-51.
76. Wagner T, Krampe H, Stawicki S, et al. Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. J Psychiatr Res. 2004;38:619-635.
77. Emrick CD. A review of psychologically oriented treatment of alcoholism: I. The use and interrelationships of outcome criteria and drinking behavior following treatment. Q J Stud Alcohol. 1974;35:523-549.
78. Finney JW, Monahan SC. The cost-effectiveness of treatment for alcoholism: a second approximation. J Stud Alcohol. 1996;57:229-243.
79. Holder H, Longabaugh R, Miller WR, Rubonis AV. The cost effectiveness of treatment for alcoholism: a first approximation. J Stud Alcohol. 1991;52:517-540.
80. McCrady BS, Langenbucher JW. Alcohol treatment and health care system reform. Arch Gen Psychiatry. 1996;53:737-746.
81. Miller WR, Brown JM, Simpson TL, et al. What works? A methodological analysis of the alcohol treatment outcome literature. In: Hester RK, Miller WR, eds. Handbook of Alcoholism Treatment Approaches: Effective Alternatives. 2nd ed. Boston, Mass: Allyn and Bacon; 1995:12-44.
82. Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol. 2001;62:211-220.
83. Miller WR, Wilbourne PL. Mesa Grande: A methodological analysis of clinical trials of treatment for alcohol use disorders. Addiction. 2002;97:265-277.
84. Miller WR, Brown JM, Simpson TL, et al. What works? A summary of alcohol tretament outcome research. In: Hester RK, Miller WR, eds. Handbook of Alcoholism Treatment Approaches: Effective Alternatives. 3rd ed. Boston, Mass: Allyn and Bacon; 2003:13-63.
85. Moos RH, Finney JW, Ouimette PC, Suchinsky RT. A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes. Alcohol Clin Exp Res. 1999;23:529-536.
86. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH Posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7-29.
87. Burtscheidt W, Woelwer W, Schwarz R, Strauss W, Gaebel W. Outpatient behaviour therapy in alcoholism: Treatment outcome after 2 years. Acta Psychiatr Scand. 2002;106:227-232.
88. Miller WR, Meyers RJ, Tonigan JS, Grant KA. Community reinforcement and traditional approaches: findings of a controlled trial. In: Meyers RJ, Miller WR, eds. A Community Reinforcement Approach to Addiction Treatment. Cambridge, Mass: Cambridge University Press; 2001:79-103.
89. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998;22:1300-1311.
90. Brewer C. Supervised disulfiram is more effective in alcoholics than naltrexone or acamprosate -or even psychotherapy: how it works and why it matters. Adicciones. 2005;17:285-296.
91. Ehrenreich H, Krampe H. Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects. Addiction. 2004;99:26-27.
92. Fuller RK, Gordis E. Does disulfiram have a role in alcoholism treatment today? Addiction. 2004;99:21-24.
93. Hughes JC, Cook CCH. The efficacy of disulfiram - a review of outcome studies. Addiction. 1997;92:381-395.
94. Krampe H, Stawicki S, Wagner T, et al. Follow-up of 180 chronic alcoholic patients for up to seven years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res. 2006;30:86-95.
95. Suh J, Pettinati H, Kampman K, O'Brien C. The status of disulfiram: a half of a century later. J Clin Psychopharmacol. 2006;26:290-302.
96. Carmen B, Angeles M, Ana M, Maria AJ. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence:a systematic review. Addiction. 2004;99:811-828.
97. O'Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry. 2005;162:1423-1431.
98. Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25:1335-1341.
99. Mann K, Lehert P, Morgan MY. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res. 2004;28:51-63.
100. Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol. 2005;8:267-280.
101. Anton R, O'Malley S, Ciraulo D, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA. 2006;295:2003-2017.
102. Ehrenreich H, Krampe H, Wagner T, et al. Outpatient long-term intensive therapy for alcoholics, "OLITA": re-considering severe alcoholism, disease and treatment. Suchtmedizin in Forschung und Praxis. 2000;2:221-222.
103. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843-861.
104. Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002;97:279-292.
105. Vasilaki EI, Hosier SG, Cox WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol. 2006;41:328-335.
106. Ehrenreich H, Mangholz A, Schmitt M, et al. OLITA: An alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach. Eur Arch Psychiatry Clin Neurosci. 1997;247:51-54.
107. Krampe H, Wagner T, Küfner H, et al. Therapist rotation - a new element in the outpatient treatment of alcoholism. Subst Use Misuse. 2004;39:135-178.
108. Krampe H, Wagner T, Stawicki S, et al. Personality disorder and chronicity of Addiction. as independent outcome predictors in alcoholism treatment. Psychiatr Serv. 2006;57:708-712.
109. Gsellhofer B, Küfner H, Vogt M, Weiler D. European Addiction. Severity Index - EuropASI. Baltmannsweiler: Schneider-Verlag Hohengehren; 1999.
110. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity index. J Subst Abuse Treat. 1992;9:199-213.
111. Bowen RC, D'Arcy C, Keegan D, Senthilselvan A. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav. 2000;25:593-597.
112. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: A first step toward developing effective treatments. Alcohol Clin Exp Res. 2001;25:210-220.
113. Bartels C, Kunert H-J, Stawicki S, Kroener-Herwig B, Ehrenreich H, Krampe H. Recovery of hippocampus-related functions in chronic alcoholics during monitored longterm abstinence. Alcohol Alcohol. 2007;42:92-102.
114. Krampe H, Stawicki S, Ribbe K, et al. Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes. J Psychiatr Res. 2007. In press.
115. Alexander LB, Luborsky L. The Penn helping alliance scales. In: Greenberg LS, Pinsof WM, eds. The Psychotherapeutic Process: a Research Handbook. New York, NY: The Guilford Press; 1986:325-366.
116. Luborsky L, McLellan AT, Woody GE, O'Brien CP, Auerbach A. Therapist success and its determinants. Arch Gen Psychiatry. 1985;42:602-611.
117. Horvath AO. The therapeutic relationship: Research and theory. Psychother Res. 2005;15:3-7.
118. Belding M, Iguchi M, Morral A, McLellan A. Assessing the helping alliance and its impact in the treatment of opiate dependence. Drug Alcohol Depend. 1997;48:51-59.
119. Fenton L, Cecero J, Nich C, Frankforter T, Carroll K. Perspective is everything: The predictive validity of six working alliance instruments. Journal Psychother Pract Res. 2001;10:262-268.
120. Meier P, Donmall M. Differences in client and therapist views of the working alliance in drug treatment. J Substance Use. 2006;11:73-80.
121. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.